Decrease in Epstein-Barr virus-positive AIDS-related lymphoma in the era of highly active antiretroviral therapy

Microbes and Infection

Volumn 8, Issue 5, 2006, Pages 1301-1307

  Hishima, Tsunekazu ^a   Oyaizu, Naoki ^b   Fujii, Takeshi ^c   Tachikawa, Natsuo ^c   Ajisawa, Atsushi ^a   Negishi, Masayoshi ^a   Nakamura, Tetsuya ^b   Iwamoto, Aikichi ^b   Hayashi, Yukiko ^a   Matsubara, Daisuke ^c   Sasao, Yuki ^c   Kimura, Satoshi ^c   Kikuchi, Yoshimi ^c   Teruya, Katsuji ^c   Yasuoka, Akira ^d   Oka, Shinichi ^c   Saito, Kiyoshi ^c   Mori, Shigeo ^e   Funata, Nobuaki ^a   Sata, Tetsutaro ^f   Katano, Harutaka ^f   more..

^a TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^d UNIVERSITY OF TOYAMA   (Japan)

^e TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

AIDS related lymphoma; Burkitt's lymphoma; Diffuse large B cell lymphoma; Epstein Barr virus; Highly active antiretroviral therapy

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; ARTICLE; AUTOPSY; B CELL LYMPHOMA; BURKITT LYMPHOMA; CANCER INCIDENCE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; HERPES VIRUS INFECTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; JAPAN; KAPOSI SARCOMA; LARGE CELL LYMPHOMA; LYMPH NODE; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BURKITT LYMPHOMA; CHILD; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HIV INFECTIONS; HUMANS; INCIDENCE; JAPAN; LYMPHOMA, AIDS-RELATED; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; MALE; MIDDLE AGED;

HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 8;

EID: 33744831160     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2005.12.012     Document Type: Article

References (40)

1. Clifford G.M., Polesel J., Rickenbach M., Dal Maso L., Keiser O., Kofler A., Rapiti E., Levi F., Jundt G., Fisch T., Bordoni A., De Weck D., and Franceschi S. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J. Natl. Cancer Inst. 97 (2005) 425-432
2. Grulich A.E., Wan X., Law M.G., Coates M., and Kaldor J.M. Risk of cancer in people with AIDS. AIDS 13 (1999) 839-843
3. Boshoff C., and Weiss R. AIDS-related malignancies. Nat. Rev. Cancer 2 (2002) 373-382
4. Carbone A. Emerging pathways in the development of AIDS-related lymphomas. Lancet Oncol. 4 (2003) 22-29
5. Dal Maso L., and Franceschi S. Epidemiology of non-Hodgkin lymphomas and other haemolymphopoietic neoplasms in people with AIDS. Lancet Oncol. 4 (2003) 110-119
6. Goedert J.J. The epidemiology of acquired immunodeficiency syndrome malignancies. Semin. Oncol. 27 (2000) 390-401
7. Mori S., Koike M., Hondo R., Wakabayashi T., Maeda Y., Kazuyama Y., Kataoka I., and Watanabe T. Malignant lymphomas in Japanese AIDS patients. Acta Pathol. Jpn. 41 (1991) 744-750
8. Katano H., Morishita Y., Cui L.X., Watanabe T., Hirai K., and Mori S. Expression of latent membrane protein 1 in clinically isolated cases and animal models of AIDS-associated non-Hodgkin's lymphomas. Pathol. Int. 46 (1996) 568-574
9. P.S. Moore, Y. Chang, Kaposi's sarcoma-associated herpesvirus, in: D.M. Knipe, P.M. Howley (Eds.), Fields Virology, fourth ed., vol. 2, Lippincott Williams & Wilkins, Philadelphia, 2001, pp. 2803-2834.
10. Nador R.G., Cesarman E., Chadburn A., Dawson D.B., Ansari M.Q., Sald J., and Knowles D.M. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood 88 (1996) 645-656
11. Katano H., Suda T., Morishita Y., Yamamoto K., Hoshino Y., Nakamura K., Tachikawa N., Sata T., Hamaguchi H., Iwamoto A., and Mori S. Human herpesvirus 8-associated solid lymphomas that occur in AIDS patients take anaplastic large cell morphology. Mod. Pathol. 13 (2000) 77-85
12. International Collaboration on HIV and Cancer. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J. Natl. Cancer Inst. 92 (2000) 1823-1830
13. Besson C., Goubar A., Gabarre J., Rozenbaum W., Pialoux G., Chatelet F.P., Katlama C., Charlotte F., Dupont B., Brousse N., Huerre M., Mikol J., Camparo P., Mokhtari K., Tulliez M., Salmon-Ceron D., Boue F., Costagliola D., and Raphael M. Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy. Blood 98 (2001) 2339-2344
14. Ledergerber B., Egger M., Erard V., Weber R., Hirschel B., Furrer H., Battegay M., Vernazza P., Bernasconi E., Opravil M., Kaufmann D., Sudre P., Francioli P., and Telenti A. AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study. JAMA 282 (1999) 2220-2226
15. Ledergerber B., Telenti A., and Egger M. Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: prospective cohort study. Swiss HIV Cohort Study. BMJ 319 (1999) 23-24
16. Mocroft A., Ledergerber B., Katlama C., Kirk O., Reiss P., d'Arminio Monforte A., Knysz B., Dietrich M., Phillips A.N., and Lundgren J.D. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet 362 (2003) 22-29
17. Tirelli U., Spina M., Gaidano G., Vaccher E., Franceschi S., and Carbone A. Epidemiological, biological and clinical features of HIV-related lymphomas in the era of highly active antiretroviral therapy. AIDS 14 (2000) 1675-1688
18. Kirk O., Pedersen C., Cozzi-Lepri A., Antunes F., Miller V., Gatell J.M., Katlama C., Lazzarin A., Skinhoj P., and Barton S.E. Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy. Blood 98 (2001) 3406-3412
19. Carrieri M.P., Pradier C., Piselli P., Piche M., Rosenthal E., Heudier P., Durant J., and Serraino D. Reduced incidence of Kaposi's sarcoma and of systemic non-Hodgkin's lymphoma in HIV-infected individuals treated with highly active antiretroviral therapy. Int. J. Cancer 103 (2003) 142-144
20. Vilchez R.A., Jorgensen J.L., and Kroll M.H. Systemic non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy. Blood 99 (2002) 4250-4251
21. Wolf T., Brodt H.R., Fichtlscherer S., Mantzsch K., Hoelzer D., Helm E.B., Mitrou P.S., and Chow K.U. Changing incidence and prognostic factors of survival in AIDS-related non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy (HAART). Leuk. Lymphoma 46 (2005) 207-215
22. Glaser S.L., Clarke C.A., Gulley M.L., Craig F.E., DiGiuseppe J.A., Dorfman R.F., Mann R.B., and Ambinder R.F. Population-based patterns of human immunodeficiency virus-related Hodgkin lymphoma in the Greater San Francisco Bay Area, 1988-1998. Cancer 98 (2003) 300-309
23. Little R.F., Pittaluga S., Grant N., Steinberg S.M., Kavlick M.F., Mitsuya H., Franchini G., Gutierrez M., Raffeld M., Jaffe E.S., Shearer G., Yarchoan R., and Wilson W.H. Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology. Blood 101 (2003) 4653-4659
24. Sukpanichnant S. Analysis of 1983 cases of malignant lymphoma in Thailand according to the World Health Organization classification. Hum. Pathol. 35 (2004) 224-230
25. Sriplung H., and Parkin D.M. Trends in the incidence of acquired immunodeficiency syndrome-related malignancies in Thailand. Cancer 101 (2004) 2660-2666
26. Young L.S., and Rickinson A.B. Epstein-Barr virus: 40 years on. Nat. Rev. Cancer 4 (2004) 757-768
27. Yu M.C., and Yuan J.M. Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol. 12 (2002) 421-429
28. Tokunaga M., Land C.E., Uemura Y., Tokudome T., Tanaka S., and Sato E. Epstein-Barr virus in gastric carcinoma. Am. J. Pathol. 143 (1993) 1250-1254
29. Kuze T., Nakamura N., Hashimoto Y., Sasaki Y., and Abe M. The characteristics of Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma: comparison between EBV(+) and EBV(-) cases in Japanese population. Jpn. J. Cancer Res. 91 (2000) 1233-1240
30. M. Raphael, B. Borisch, E.S. Jaffe, Lymphomas associated with infection by the human immune deficiency virus (HIV), in: E.S. Jaffe, N.L. Harris, H. Stein, J.W. Vardiman (Eds.), Tumours of Haematopoetic and Lymphoid Tissues, IARC press, Lyon, 2001, pp. 260-263.
31. Howe J.G., and Steitz J.A. Localization of Epstein-Barr virus-encoded small RNAs by in situ hybridization. Proc. Natl. Acad. Sci. U.S.A. 83 (1986) 9006-9010
32. Katano H., Sato Y., Kurata T., Mori S., and Sata T. High expression of HHV-8-encoded ORF73 protein in spindle-shaped cells of Kaposi's sarcoma. Am. J. Pathol. 155 (1999) 47-52
33. Yamamoto Y., Teruya K., Katano H., Niino H., Yasuoka A., Kimura S., and Oka S. Rapidly progressive human herpesvirus 8-associated solid anaplastic lymphoma in a patient with AIDS-associated Kaposi sarcoma. Leuk. Lymphoma 44 (2003) 1631-1633
34. Katano H., Hoshino Y., Morishita Y., Nakamura T., Satoh H., Iwamoto A., Herndier B., and Mori S. Establishing and characterizing a CD30-positive cell line harboring HHV-8 from a primary effusion lymphoma. J. Med. Virol. 58 (1999) 394-401
35. Masliah E., DeTeresa R.M., Mallory M.E., and Hansen L.A. Changes in pathological findings at autopsy in AIDS cases for the last 15 years. AIDS 14 (2000) 69-74
36. Gatter K.C., and Warnke R.A. Diffuse large B-cell lymphoma. In: Jaffe E.S., Harris N.L., Stein H., and Vardiman J.W. (Eds). Tumours of Haematopoetic and Lymphoid Tissues (2001), IARC press, Lyon 171-174
37. Takeuchi K., Morishita Y., Fukayama M., and Mori S. Marked decrease in the Epstein-Barr virus positivity rate in nodular sclerosis subtype Hodgkin's disease in Tokyo: trend between 1955 and 1999. Br. J. Haematol. 113 (2001) 429-431
38. Takeuchi K., Tanaka-Taya K., Kazuyama Y., Ito Y.M., Hashimoto S., Fukayama M., and Mori S. Prevalence of Epstein-Barr virus in Japan: trends and future prediction. Pathol. Int. 56 (2006) 112-116
39. Hashido M., Kawana T., Matsunaga Y., and Inouye S. Changes in prevalence of herpes simplex virus type 1 and 2 antibodies from 1973 to 1993 in the rural districts of Japan. Microbiol. Immunol. 43 (1999) 177-180
40. Hoshiba T., Asamoto A., and Yabuki Y. Decreasing seropositivity of cytomegalovirus of pregnant women in Japan. Nippon Rinsho 56 (1998) 193-196